Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
As of close of business last night, Nuvation Bio Inc’s stock clocked out at $2.05, up 0.99% from its previous closing price of $2.03. In other words, the price has increased by $0.99% from its previous closing price. On the day, 6.18 million shares were traded. NUVB stock price reached its highest trading level at $2.14 during the session, while it also had its lowest trading level at $2.03.
Ratios:
To gain a deeper understanding of NUVB’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.01 and its Current Ratio is at 9.01. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citizens JMP on April 23, 2025, initiated with a Mkt Outperform rating and assigned the stock a target price of $6.
On March 27, 2024, Jefferies Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $1.40 to $10.
BTIG Research Upgraded its Neutral to Buy on March 26, 2024, while the target price for the stock was maintained at $5.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 18 ’25 when Markel Stacy bought 10,000 shares for $1.71 per share. The transaction valued at 17,100 led to the insider holds 29,591 shares of the business.
Sauvage Philippe bought 4,000 shares of NUVB for $7,160 on Jun 17 ’25. The Chief Financial Officer now owns 9,902 shares after completing the transaction at $1.79 per share. On Jun 16 ’25, another insider, Sauvage Philippe, who serves as the Chief Financial Officer of the company, bought 3,300 shares for $1.83 each. As a result, the insider paid 6,056 and bolstered with 5,902 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NUVB now has a Market Capitalization of 697539136 and an Enterprise Value of 247276096. For the stock, the TTM Price-to-Sale (P/S) ratio is 63.64 while its Price-to-Book (P/B) ratio in mrq is 1.66. Its current Enterprise Value per Revenue stands at 22.568 whereas that against EBITDA is -1.204.
Stock Price History:
The Beta on a monthly basis for NUVB is 1.37, which has changed by -0.31438124 over the last 52 weeks, in comparison to a change of 0.11213791 over the same period for the S&P500. Over the past 52 weeks, NUVB has reached a high of $3.97, while it has fallen to a 52-week low of $1.54. The 50-Day Moving Average of the stock is -4.70%, while the 200-Day Moving Average is calculated to be -13.37%.
Shares Statistics:
It appears that NUVB traded 4.81M shares on average per day over the past three months and 10778170 shares per day over the past ten days. A total of 338.84M shares are outstanding, with a floating share count of 226.12M. Insiders hold about 33.54% of the company’s shares, while institutions hold 48.62% stake in the company. Shares short for NUVB as of 1748563200 were 42326428 with a Short Ratio of 8.80, compared to 1745971200 on 33098485. Therefore, it implies a Short% of Shares Outstanding of 42326428 and a Short% of Float of 20.369999999999997.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
